Clinical Trials Sponsored by Cantero Therapeutics, a BridgeBio company
Total 158 results
-
Cantero Therapeutics, a BridgeBio companyCelerionCompleted
-
Eidos Therapeutics, a BridgeBio companyCompletedFamilial ATTR-CM (ATTRm-CM, or FAC) | Wild-type ATTR-CM (ATTRwt-CM)United States
-
Eidos Therapeutics, a BridgeBio companyWithdrawnTransthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
-
Eidos Therapeutics, a BridgeBio companyActive, not recruitingAmyloid Cardiomyopathy, Transthyretin-RelatedUnited States, Spain, Australia, Canada, Italy, Netherlands, Ireland, New Zealand, Belgium, Israel, Greece, Korea, Republic of, Czechia, Brazil, Denmark, Portugal, United Kingdom
-
Eidos Therapeutics, a BridgeBio companyCompletedHeart Diseases | Amyloidosis | Cardiomyopathies | Transthyretin Amyloidosis | Amyloid CardiomyopathyUnited States, Netherlands, Ireland, Canada, Italy, Spain, Belgium, New Zealand, Israel, Australia, Portugal, Brazil, Poland, Czechia, Denmark, Greece, Korea, Republic of, United Kingdom
-
Eidos Therapeutics, a BridgeBio companyActive, not recruiting
-
Eidos Therapeutics, a BridgeBio companyCompleted
-
Eidos Therapeutics, a BridgeBio companyWithdrawnTransthyretin-Related (ATTR) Familial Amyloid PolyneuropathyUnited States
-
Calcilytix Therapeutics, Inc., a BridgeBio companyRecruitingAutosomal Dominant HypocalcemiaUnited States, France, Denmark, Australia, Japan, Belgium, Canada, Italy, Netherlands, United Kingdom, Portugal, Finland, Germany
-
Calcilytix Therapeutics, Inc., a BridgeBio companyRecruitingAutosomal Dominant Hypocalcemia (ADH)United States, Australia, Denmark, Italy, France, Japan, Canada, Czechia, Netherlands
-
Calcilytix Therapeutics, Inc., a BridgeBio companyCompletedAutosomal Dominant Hypocalcemia (ADH)United States
-
Eidos Therapeutics, a BridgeBio companyCelerionCompletedAmyloid Cardiomyopathy, Transthyretin-RelatedUnited States
-
CoA Therapeutics, Inc., a BridgeBio companyTerminatedHealthy Volunteers | Propionic Acidemia | Methylmalonic Acidemia | Organic AcidemiaUnited States
-
Alexion Pharmaceuticals, Inc.Eidos Therapeutics, a BridgeBio companyActive, not recruitingSymptomatic Transthyretin Amyloid CardiomyopathyJapan
-
Venthera, Inc., a BridgeBio companyTerminatedLymphatic Malformation | Venous Malformation | Venolymphatic MalformationUnited States
-
Navire Pharma Inc., a BridgeBio companyActive, not recruitingTumor, SolidUnited States
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
Massachusetts General HospitalPfizer; Akcea Therapeutics; Alnylam Pharmaceuticals; Eidos Therapeutics, a BridgeBio...RecruitingHeart Failure | Amyloidosis | Heart Failure, Diastolic | Transthyretin AmyloidosisUnited States
-
Navire Pharma Inc., a BridgeBio companyBristol-Myers SquibbRecruitingSolid Tumor | Non Small Cell Lung CancerUnited States
-
Phoenix Tissue Repair, Inc.Phoenix Tissue Repair, a BridgeBio companyCompletedRecessive Dystrophic Epidermolysis BullosaUnited States
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular DystrophyUnited States
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, United Kingdom
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, Belgium, Australia, Canada, France, Germany, Israel, Italy, Spain, Sweden, United Kingdom
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedHemophilia A | Hemophilia BUnited States, Canada, France, Italy
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedAmino Acid Metabolism, Inborn ErrorsFrance, United Kingdom, Italy, Belgium, Germany, Switzerland
-
Fred Hutchinson Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Adult Acute Lymphoblastic Leukemia | Refractory Diffuse... and other conditionsUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingRelapsed and/or Refractory Multiple MyelomaUnited States, France, Spain, Germany
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Vanderbilt-Ingram Cancer CenterKite, A Gilead CompanyActive, not recruitingDiffuse Large B-cell Lymphoma | Large B-cell LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterKite, A Gilead CompanyCompletedClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminatedLymphoma | Leukemia | Myelodysplastic Syndrome | Hematological MalignanciesUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminatedAcute Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Texas Oncology Cancer CenterGenzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Burkitt's LymphomaUnited States
-
Cancer Center of IrvineGenzyme, a Sanofi CompanyCompletedProstate CancerUnited States
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Disorder With HyperactivityUnited States
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyWithdrawnLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminatedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedLeukemia | Stem Cell TransplantationUnited States